This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2010 Jul;139(1):7-13.e3.

doi: 10.1053/j.gastro.2010.05.016. Epub 2010 May 20.

Persistent reflux symptoms in the proton pump inhibitor era: the changing face of gastroesophageal reflux disease

Evan S Dellon¹, Nicholas J Shaheen

Affiliations

Affiliation

¹ Center for Esophageal Diseases and Swallowing and Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

PMID: 20493864
DOI: 10.1053/j.gastro.2010.05.016

Review

Persistent reflux symptoms in the proton pump inhibitor era: the changing face of gastroesophageal reflux disease

Evan S Dellon et al. Gastroenterology. 2010 Jul.

. 2010 Jul;139(1):7-13.e3.

doi: 10.1053/j.gastro.2010.05.016. Epub 2010 May 20.

Authors

Evan S Dellon¹, Nicholas J Shaheen

Affiliation

¹ Center for Esophageal Diseases and Swallowing and Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

PMID: 20493864
DOI: 10.1053/j.gastro.2010.05.016

No abstract available

PubMed Disclaimer

Similar articles

Reflux inhibitors: a new approach for GERD?
Boeckxstaens GE. Boeckxstaens GE. Curr Opin Pharmacol. 2008 Dec;8(6):685-9. doi: 10.1016/j.coph.2008.08.005. Epub 2008 Sep 17. Curr Opin Pharmacol. 2008. PMID: 18771751 Review.
New therapies for gastroesophageal reflux disease.
Bredenoord AJ. Bredenoord AJ. Minerva Gastroenterol Dietol. 2010 Jun;56(2):129-38. Minerva Gastroenterol Dietol. 2010. PMID: 20485251 Review.
Proton pump inhibitor failure--what are the therapeutic options?
Fass R. Fass R. Am J Gastroenterol. 2009 Mar;104 Suppl 2:S33-8. doi: 10.1038/ajg.2009.50. Am J Gastroenterol. 2009. PMID: 19262545 Review.
Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease.
Tack J. Tack J. Curr Opin Gastroenterol. 2005 Jul;21(4):454-60. Curr Opin Gastroenterol. 2005. PMID: 15930988 Review.
Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
Sweis R, Anggiansah A, Wong T. Sweis R, et al. Clin Gastroenterol Hepatol. 2010 Mar;8(3):313. doi: 10.1016/j.cgh.2009.09.023. Epub 2009 Sep 26. Clin Gastroenterol Hepatol. 2010. PMID: 19788931 No abstract available.

See all similar articles

Cited by

Do proton pump inhibitors prevent Barrett's esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis.
Chen Y, Sun C, Wu Y, Chen X, Kailas S, Karadsheh Z, Li G, Guo Z, Yang H, Hu L, Zhou Q. Chen Y, et al. J Cancer Res Clin Oncol. 2021 Sep;147(9):2681-2691. doi: 10.1007/s00432-021-03544-3. Epub 2021 Feb 11. J Cancer Res Clin Oncol. 2021. PMID: 33575855 Free PMC article.
Quality of Life in Gastroesophageal Reflux Disease Three Months After Laparoscopic Nissen's Fundoplication.
Kumar A, Raja K, Kumar S, Quasimuddin N, Rizwan A. Kumar A, et al. Cureus. 2020 Sep 26;12(9):e10674. doi: 10.7759/cureus.10674. Cureus. 2020. PMID: 33133840 Free PMC article.
Refractory Gastroesophageal Reflux Disease: A Management Update.
Rettura F, Bronzini F, Campigotto M, Lambiase C, Pancetti A, Berti G, Marchi S, de Bortoli N, Zerbib F, Savarino E, Bellini M. Rettura F, et al. Front Med (Lausanne). 2021 Nov 1;8:765061. doi: 10.3389/fmed.2021.765061. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34790683 Free PMC article. Review.
A preliminary report on the use of Midodrine in treating refractory gastroesophageal disease: Randomized Double-Blind Controlled Trial.
Bagheri Lankarani K, Sivandzadeh GR, Zare M, Nejati M, Niknam R, Taghavi AR, Ejtehadi F, Naini MA, Moini M, Anbardar MH, Peymani P. Bagheri Lankarani K, et al. Acta Biomed. 2020 Mar 19;91(1):70-78. doi: 10.23750/abm.v91i1.8486. Acta Biomed. 2020. PMID: 32191657 Free PMC article. Clinical Trial.
Efficacy of Shugan Hewei formula combined with rabeprazole in refractory gastroesophageal reflux disease: randomized, double-blind, placebo-controlled trial.
Zhang X, Wang Z, Xu T, Wei L, Liu F, Liu C, Li L, Zhang W, Zhu S. Zhang X, et al. Eur J Med Res. 2024 Sep 19;29(1):466. doi: 10.1186/s40001-024-02030-z. Eur J Med Res. 2024. PMID: 39300586 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information